- Home
- GERN vs NUS Comparison
GERN vs NUS Comparison
Compare GERN & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GERN | NUS |
|---|---|---|
| Founded | 1990 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.3M | 603.4M |
| IPO Year | 1996 | 1996 |
Fundamental Metrics
Financial Performance| Metric | GERN | NUS |
|---|---|---|
| Price | $1.37 | $9.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $3.00 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 6.7M | 447.6K |
| Earning Date | 11-05-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.20 |
| Revenue | $183,403,000.00 | ★ $1,560,391,000.00 |
| Revenue This Year | $147.42 | N/A |
| Revenue Next Year | $39.42 | $2.12 |
| P/E Ratio | ★ N/A | $4.57 |
| Revenue Growth | ★ 522.13 | N/A |
| 52 Week Low | $1.04 | $5.32 |
| 52 Week High | $3.68 | $14.62 |
Technical Indicators
Market Signals| Indicator | GERN | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | 43.37 |
| Support Level | $1.30 | $9.94 |
| Resistance Level | $1.37 | $10.35 |
| Average True Range (ATR) | 0.08 | 0.30 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 64.58 | 20.72 |
Price Performance
Historical ComparisonAbout GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.